Clindamycin
Clindamycin is a pharmaceutical product used in a laboratory setting for research and testing purposes. It is an antibiotic agent that can be utilized in various scientific experiments and analyses. The core function of Clindamycin is to serve as a tool for researchers and scientists to study its properties and potential applications.
Lab products found in correlation
24 protocols using clindamycin
Antibiotic Susceptibility Testing Protocol
Antimicrobial Susceptibility of MRSA Isolates
Antibiotic Susceptibility of Common Bacterial Strains
Antimicrobial Susceptibility of S. aureus
Antibiotic Susceptibility Testing of Isolated Organisms
Bacteriological Analysis and Antibiotic Susceptibility
Purified bacterial isolates were subjected to drug susceptibility tests using the Kirby Bauer disc diffusion method [14 ]. Commercially available antibiotic discs that were used include: ciprofloxacin, norfloxacin, gentamycin, erythromycin, clindamycin, cephalexin, co-trimoxazole, tetracycline, cefoxitin, ampicillin, vancomycin and chloramphenicol (Hi Media Laboratories Pvt. Ltd, India). These antibiotics were chosen based on the type of microorganisms frequently isolated and their availability at University Teaching Hospital.
MRSA Antimicrobial Susceptibility Testing
the modified Kirby-Bauer disk diffusion method according to the clinical
laboratory standard institute (CLSI) guidelines (CLSI 2013 ). The following antimicrobials were used in
their respective concentration: Ciprofloxacin (5 μg),
Trimethoprim-Sulfamethoxazole (1.25/23.75 μg), Erythromycin (15 μg), Clindamycin
(2 μg), and Amikacin (30 μg) (Hi-Media, India). These antimicrobials were selected
based on the local usage to treat MRSA and considering the recommended
antimicrobial agents for MRSA infections.
Antimicrobial Resistance Profiling of Clinical Isolates
Isolates were considered multidrug resistant (MDR) based on the guidelines recommended by the joint initiative of the European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC).17 (link) According to those guidelines, the isolates showing non-susceptibility to at least one agent in three or more antimicrobial categories were identified as MDR.
S. aureus isolates showing positive D zone test were considered as resistant to clindamycin.
Antibiotic Susceptibility Testing Protocol
Evaluation of Antibacterial and Antifungal Activities
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!